Autumn has passed and winter has arrived, and the grand event has begun. From November 20th to November 22nd, the 89th PHARMACHINA & 2024 China International Natural Health & Nutrition Expo(NHNE) was grandly opened at the Wuhan International Expo Center. This conference aims to meet the new needs of the pharmaceutical and health industry from three dimensions: empowering the industry, connecting resources, and learning and exchange, injecting strong impetus into the industry's innovative development.
During the exhibition, the atmosphere was unprecedented and exciting! SINO Universal Pharmaceutical displayed multiple products and its member company Nanjing Vtrying Pharmaceutical Technology Co., Ltd. participated in the exhibition together. SINO Universal Pharmaceutical has open exchanges with industry experts, association scholars, and business partners attending the conference to discuss the trends of industry transformation in the new era and share the achievements of new policy market development.
SINO Universal Pharmaceutical displayed its full range of products at this exhibition, including 22 approved products, 4 selected products from national procurement, 5 selected products from provincial procurement, 6 products are under applying for GQCE, 13 products under licensing, and 35 self-developed certified products from SINO Universal in the future. Multiple heavyweight products, such as Dapagliflozin tablets, Sevelamer carbonate tablets, Fulvestrant injection, Pregabalin oral solution, Pantoprazole sodium Tablet, delayed release, etc., have attracted much attention.
Mr. Li Wang, CEO of SINO Universal Pharmaceutical Group, personally visited the exhibition site, and the marketing team contacted numerous domestic and foreign partners. Mr. Yu Dunyang, Director of the Group's Human Resources Department, accepted a live interview with the drug screening platform on site. SINO Universal Pharmaceutical will continue to build a product synergy matrix advantage of "global licensed+self-developed drive", always adhere to the product strategic positioning of "Generic Drug cultivates innovation route and both types combined", continuously improve the distribution of the industrial chain, accelerate the process of international cooperation, and build innovative partnerships. Through more high-quality products, SINO Universal Pharmaceutical will benefit the vast number of patients and contribute SINO Universal’s strength to the Healthy China strategy!
